Genital warts in men: A large population-based cross-sectional survey of Danish men

Sexually Transmitted Infections

Volumn 88, Issue 8, 2012, Pages 640-644

  Munk, Christian ^a   Nielsen, Ann ^a   Liaw, Kai Li ^b   Kjaer, Susanne Krüger ^a,c  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DENMARK; HUMAN; INFORMATION PROCESSING; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOM SAMPLE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SELF REPORT; SEXUALLY TRANSMITTED DISEASE; SMOKING;

ADOLESCENT; ADULT; CONDYLOMATA ACUMINATA; CROSS-SECTIONAL STUDIES; DENMARK; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; YOUNG ADULT;

EID: 84871618600     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2012-050512     Document Type: Article

References (33)

1. Muñoz N, Castellsagué X, de González AB, et al. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006;24S3:S1-10.
2. Clarke P, Ebel C, Catotti DN, et al. The psychosocial impact of human papillomavirus infection: implications for health care providers. Int J STD AIDS 1996;7:197-200. (Pubitemid 26191688)
3. Maw RD, Reitano M, Roy M. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998;9:571-8. (Pubitemid 28474812)
4. Hu D, Goldie S. The economic burden of noncervical human papillomavirus disease in the United States. Am J Obstet Gynecol 2008;198:500.e1-7.
5. Insinga RP, Dasbach EJ, Myers ER. The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis 2003;36:1397-403. (Pubitemid 36702873)
6. Brown RE, Breugelmans JG, Theodoratou D, et al. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK. Curr Med Res Opin 2006;22:663-70.
7. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006;24(Suppl 3):35-41.
8. Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011;364:401-11.
9. Approval Letter, Gardasil 16 October 2009. http://www.fda.gov/ BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186991.htm (accessed 4 April 2011).
10. Approval Letter, Gardasil 22 December 2010. http://www.fda.gov/ BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm238074.htm (accessed 4 April 2011).
11. Kjaer SK, Tran TN, Sparen P, et al. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 2007; 196:1447-54. (Pubitemid 351411979)
12. Grulich AE, de Visser RO, Smith AMA, et al. Sex in Australia: sexually transmissible infection and blood-borne virus history in a representative sample of adults. Aust N Z J Public Health 2003;27:234-41. (Pubitemid 36526897)
13. Klavs I, Grgic-Vitek M. The burden of genital warts in Slovenia: results from a national probability sample survey. Euro Surveill 2008;13:pii:19032.
14. Kjaer SK, Munk C, Winther JF, et al. Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 2005;14:1528-33. (Pubitemid 40807357)
15. Lajous M, Mueller N, Cruz-Valdéz A, et al. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev 2005;14:1710-16. (Pubitemid 40995084)
16. Partridge JM, Hughes JP, Feng Q, et al. Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis 2007;196:1128-36. (Pubitemid 47580267)
17. Giuliano AR, Lazcano-Ponce E, Villa LL, et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008;17:2036-43.
18. Dinh T-H, Sternberg M, Dunne EF, et al. Genital warts among 18- to 59-year-olds in the United States, National Health and Nutrition Survey, 1999-2004. Sex Transm Dis 2008;35:357-60. (Pubitemid 351440776)
19. Woodhall S, Ramsey T, Cai C, et al. Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect 2008;84:161-6. (Pubitemid 351871484)
20. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital disease. N Engl J Med 2007;356:1928-43. (Pubitemid 46740303)
21. Dillner J, Kjaer SK, Wheeler CM, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and genital warts: randomised controlled trial. BMJ 2010;340:c3493.
22. Donovan B, Franklin N, Guy R, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011;11:39-44.
23. Read TRH, Hocking JS, Chen MY, et al. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 2011;87:544-7.
24. Garland SM, Steben M, Sings HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009;199:805-14.
25. Koshiol JE, Laurent SA, Pimenta JM. Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States. Sex Transm Dis 2004;31:748-52. (Pubitemid 39557423)
26. Wiley DJ, Elashoff D, Masongsong EV, et al. Smoking enhances risk for new external genital warts in men. Int J Environ Public Health 2009;6:1215-34.
27. Hansen BT, Hagerup-Jenssen M, Kjaer SK, et al. Association between smoking and genital warts: longitudinal analysis. Sex Transm Infect 2010;86:258-62.
28. Castellsagué X, Bosch FX, Muñoz N, et al. Male circumsion, penile papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002;346:1105-12. (Pubitemid 34984600)
29. Gray RH, Serwadda D, Kong X, et al. Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda. J Infect Dis 2010;201:1455-62.
30. Hoy T, Singhal PK, Wiley VJ, et al. Assessing incidence and economic burden of genital warts with data from a US commercially insured population. Curr Med Res Opin 2009;25:2343-51.
31. Wiley DJ, Grosser S, Qi K, et al. Validity of self-reporting of episodes of external genital warts. Clin Infect Dis 2002; 35:39-45. (Pubitemid 34666858)
32. Johnson AM, Mercer CH, Erens B, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet 2001;358:1835-42. (Pubitemid 34008648)
33. Hargreave M, Nielsen A, Munk C, et al. Continuous regular use of mild analgesics in Denmark (in Danish). Ugeskr Laeger 2010;172:2295-302.